Biotest Divestiture Trust 3
3 · ADMA BIOLOGICS, INC. · Filed Aug 9, 2018
Insider Transaction Report
Form 3
Biotest Divestiture Trust
10% Owner
Holdings
- 8,591,160(indirect: By Biotest Pharmaceuticals Corporation)
Non-Voting Common Stock
- 10,109,534(indirect: By Biotest Pharmaceuticals Corporation)
Common Stock
Footnotes (1)
- [F1]Represents securities owned by Biotest Pharmaceuticals Corporation ("BPC"). BPC is a wholly-owned subsidiary of Biotest US Corporation ("Biotest US"), which is wholly-owned by The Biotest Divestiture Trust (the "Trust"). Eric Rosenbach, the trustee of the Trust, is the sole director of each of BPC and Biotest US and has voting and investment discretion with respect to the securities of the issuer held by BPC. Mr. Rosenbach has no pecuniary interest in such securities.